| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.2 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.33 | 0.02 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.14 | 0.7 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |